000 02395nam a22005295i 4500
001 978-94-007-0344-5
003 DE-He213
005 20140220083829.0
007 cr nn 008mamaa
008 110815s2011 ne | s |||| 0|eng d
020 _a9789400703445
_9978-94-007-0344-5
024 7 _a10.1007/978-94-007-0344-5
_2doi
050 4 _aRC261-271
072 7 _aMJCL
_2bicssc
072 7 _aMED062000
_2bisacsh
082 0 4 _a614.5999
_223
100 1 _aHayat, M. A.
_eeditor.
245 1 0 _aTumors of the Central Nervous System, Volume 1
_h[electronic resource] :
_bGliomas: Glioblastoma (Part 1) /
_cedited by M. A. Hayat.
264 1 _aDordrecht :
_bSpringer Netherlands,
_c2011.
300 _aXXII, 434 p.
_bonline resource.
336 _atext
_btxt
_2rdacontent
337 _acomputer
_bc
_2rdamedia
338 _aonline resource
_bcr
_2rdacarrier
347 _atext file
_bPDF
_2rda
490 1 _aTumors of the Central Nervous System ;
_v1
520 _aThe most recent developments in diagnostic and therapeutic aspects of Gliomas (Glioblastoma) in the brain are presented. The importance of personalized medicine and clinical validation for targeted therapy are discussed. The identification of various types of biomarkers is included. The identification and validation of brain cancer (glioblastoma) genes are discussed. Role of cancer stem cells in the initiation, progression, and persistence of malignant gliomas is explained. The use of surgical resection, chemotherapy (e.g., temozolomide), immunotherapy, and radiotherapy for malignant glioblastoma are pointed out. Standard (established) as well as newer imaging modalities (proton magnetic resonance spectroscopy) are discussed.
650 0 _aMedicine.
650 0 _aOncology.
650 0 _aRadiology, Medical.
650 0 _aNeurosurgery.
650 0 _aPathology.
650 0 _aSurgery.
650 1 4 _aBiomedicine.
650 2 4 _aCancer Research.
650 2 4 _aNeuroradiology.
650 2 4 _aNeurosurgery.
650 2 4 _aOncology.
650 2 4 _aPathology.
650 2 4 _aSurgery.
710 2 _aSpringerLink (Online service)
773 0 _tSpringer eBooks
776 0 8 _iPrinted edition:
_z9789400703438
830 0 _aTumors of the Central Nervous System ;
_v1
856 4 0 _uhttp://dx.doi.org/10.1007/978-94-007-0344-5
912 _aZDB-2-SBL
999 _c109262
_d109262